These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10794111)

  • 1. Cost and public perception.
    Allain JP
    Dev Biol (Basel); 2000; 102():229-35. PubMed ID: 10794111
    [No Abstract]   [Full Text] [Related]  

  • 2. Worldwide perspective in transfusion safety: Europe.
    Reesink HW; Strengers PE
    Dev Biol (Basel); 2000; 102():205-10. PubMed ID: 10794107
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of new blood safety technologies.
    AuBuchon JP
    Dev Biol (Basel); 2000; 102():211-5. PubMed ID: 10794108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of TSE agents from blood products.
    Foster PR
    Vox Sang; 2004 Jul; 87 Suppl 2():7-10. PubMed ID: 15209867
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety assurance for biologics manufactured in mammalian cell cultures: a multitiered strategy.
    Chen D
    Adv Biochem Eng Biotechnol; 2014; 139():167-83. PubMed ID: 23719711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserving public confidence.
    Lancet Oncol; 2008 Jun; 9(6):503. PubMed ID: 18510980
    [No Abstract]   [Full Text] [Related]  

  • 7. The problem with the double-edged solution.
    Czap A
    Altern Med Rev; 2009 Jun; 14(2):96-8. PubMed ID: 19594219
    [No Abstract]   [Full Text] [Related]  

  • 8. Worth the cost?
    Ortolon K
    Tex Med; 2004 Jan; 100(1):43-5. PubMed ID: 15146771
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sanitary control of cosmetics].
    Bonini M; Pellino P; Pilla M
    Ig Sanita Pubbl; 2005; 61(3):271-84. PubMed ID: 17206194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International acceptance of blood and blood products.
    Petricciani JC
    Dev Biol (Basel); 2000; 102():3-8. PubMed ID: 10794085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the validation of viral inactivation in biologic products.
    Aronson DL
    Prog Clin Biol Res; 1990; 324():137-49. PubMed ID: 2408050
    [No Abstract]   [Full Text] [Related]  

  • 12. Points to consider on virus safe plasma products.
    Biologicals; 1995 Jun; 23(2):193-5. PubMed ID: 7546664
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral safety of biological products and the concept of validation.
    Horaud F
    Dev Biol Stand; 1996; 88():19-24. PubMed ID: 9119135
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety].
    De Pauw BE; Van den Bos A
    Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk reduction in biotherapeutic products.
    Ill CR; Dehghani H
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems of contamination, exposure, and pollution in freeze-drying biological products.
    LaSalle B
    Dev Biol Stand; 1976 Oct; 36():201-5. PubMed ID: 1030420
    [No Abstract]   [Full Text] [Related]  

  • 17. Virus inactivation of fresh plasma.
    Mohr H
    Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems in microbial safety of advanced therapy medicinal products. Squaring the circle].
    Montag-Lessing T; Störmer M; Schurig U; Brachert J; Bubenzer M; Sicker U; Beshir R; Spreitzer I; Löschner B; Bache C; Becker B; Schneider CK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):45-51. PubMed ID: 20012926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licensing of protein products from the milk of transgenic animals. Validation for pathogen removal--a strategy.
    Wright G; Colman A; Cottom D; Williams M
    Dev Biol Stand; 1996; 88():269-76. PubMed ID: 9119150
    [No Abstract]   [Full Text] [Related]  

  • 20. Massively parallel sequencing: a new tool in virus discovery and vaccine safety.
    Onions D
    Bull Mem Acad R Med Belg; 2011; 166(10-12):404-6. PubMed ID: 23082505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.